Cipla Europe: what changed
What changed
Cipla Europe
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
-€1.3m
2024 · -€1.3m-€53,224
Equity
€3.5m
2024 · €4.8m-€1.3m
Cash
€929,317
2024 · €18,502+€910,816
Balance sheet total
€40.8m
2024 · €39.0m+€1.8m
Largest movements
Assets
- Receivables within one year +€1.3m
up €1.3m (+4.0%), from €31.1m to €32.4m
of which Trade receivables: +€1.5m
- Cash +€910,816
up €910,816 (+4,923%), from €18,502 to €929,317
mainly Trade debts (+€5.5m) and Tax, wage and social debts (+€464,924)
- Stocks and contracts -€410,920
down €410,920 (-6.5%), from €6.4m to €5.9m
Equity and liabilities
- Trade debts +€5.5m
up €5.5m (+18.8%), from €29.3m to €34.8m
- Short-term financial debts -€2.5m
down €2.5m (-77.3%), from €3.2m to €736,191
- Profit (loss) carried forward -€1.3m
down €1.3m (-55.1%), from -€2.4m to -€3.7m
- Tax, wage and social debts +€464,924
up €464,924 (+146%), from €318,248 to €783,172
of which Taxes: +€415,058
Income statement
- Turnover +€3.2m
up €3.2m (+15.0%), from €21.6m to €24.8m
- Goods and materials +€2.2m
up €2.2m (+19.6%), from €11.0m to €13.2m
of which Purchases: +€5.7m
- Services and other goods -€1.9m
down €1.9m (-21.5%), from €9.0m to €7.1m
- Write-downs +€1.8m
up €1.8m (+832%), from €217,708 to €2.0m
- Financial charges +€805,233
up €805,233 (+180%), from €448,230 to €1.3m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€1.3m
Turnover
+€3.2m
Other operating income
-€571,649
Goods and materials
-€2.2m
Services and other goods
+€1.9m
Staff costs
-€593,010
Depreciation
+€29,076
Write-downs
-€1.8m
Other operating charges
+€372,440
Other operating items
+€150,412
Financial income
+€205,396
Financial charges
-€805,233
Taxes
-€44,579
Result 2025
-€1.3m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€3.7m
Investment
-€254,128
Financing
-€2.5m
Cash 2024
€18,502
From operations (derived)
+€3.7m
Net result for the year
-€1.3m
Depreciation
+€232,697
Stocks and contracts
+€410,920
Receivables within one year
-€1.3m
Deferred charges and accrued income
-€35,112
Trade debts
+€5.5m
Tax, wage and social debts
+€464,924
Other debts
+€4,868
Accrued charges and deferred income
-€333,063
Investment (derived)
-€254,128
Investment in fixed assets (net)
-€254,128
Financing
-€2.5m
Short-term financial debts
-€2.5m
Cash 2025
€929,317
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €38,952,297 | €40,760,009 | +€1.8m | +4.6% |
| Fixed assets | 21/28 | €1,335,044 | €1,356,475 | +€21,431 | +1.6% |
| Intangible fixed assets | 21 | €1,213,173 | €1,236,307 | +€23,134 | +1.9% |
| Tangible fixed assets | 22/27 | €30,008 | €28,108 | -€1,900 | -6.3% |
| Plant, machinery and equipment | 23 | €28,058 | €27,004 | -€1,054 | -3.8% |
| Furniture and vehicles | 24 | €1,950 | €1,104 | -€846 | -43.4% |
| Financial fixed assets | 28 | €91,863 | €92,060 | +€197 | +0.2% |
| Other financial fixed assets | 284/8 | €91,863 | €92,060 | +€197 | +0.2% |
| Amounts receivable and cash guarantees | 285/8 | €91,863 | €92,060 | +€197 | +0.2% |
| Current assets | 29/58 | €37,617,252 | €39,403,533 | +€1.8m | +4.7% |
| Stocks and contracts in progress | 3 | €6,354,344 | €5,943,424 | -€410,920 | -6.5% |
| Stocks | 30/36 | €6,354,344 | €5,943,424 | -€410,920 | -6.5% |
| Goods purchased for resale | 34 | €6,354,344 | €5,943,424 | -€410,920 | -6.5% |
| Amounts receivable within one year | 40/41 | €31,126,189 | €32,377,462 | +€1.3m | +4.0% |
| Trade receivables | 40 | €30,384,160 | €31,921,304 | +€1.5m | +5.1% |
| Other amounts receivable | 41 | €742,029 | €456,159 | -€285,870 | -38.5% |
| Cash at bank and in hand | 54/58 | €18,502 | €929,317 | +€910,816 | +4,923% |
| Deferred charges and accrued income | 490/1 | €118,218 | €153,330 | +€35,112 | +29.7% |
| Total equity and liabilities | 10/49 | €38,952,297 | €40,760,009 | +€1.8m | +4.6% |
| Equity | 10/15 | €4,816,121 | €3,495,902 | -€1.3m | -27.4% |
| Contributions | 10/11 | €7,100,000 | €7,100,000 | = | 0.0% |
| Capital | 10 | €7,100,000 | €7,100,000 | = | 0.0% |
| Issued capital | 100 | €7,100,000 | €7,100,000 | = | 0.0% |
| Reserves | 13 | €110,272 | €110,272 | = | 0.0% |
| Non-distributable reserves | 130/1 | €110,272 | €110,272 | = | 0.0% |
| Legal reserve | 130 | €110,272 | €110,272 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€2,394,151 | -€3,714,370 | -€1.3m | -55.1% |
| Provisions and deferred taxes | 16 | €378,000 | €378,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €378,000 | €378,000 | = | 0.0% |
| Other liabilities and charges | 164/5 | €378,000 | €378,000 | = | 0.0% |
| Amounts payable | 17/49 | €33,758,176 | €36,886,107 | +€3.1m | +9.3% |
| Amounts payable within one year | 42/48 | €32,842,485 | €36,303,479 | +€3.5m | +10.5% |
| Financial debts | 43 | €3,240,924 | €736,191 | -€2.5m | -77.3% |
| Credit institutions | 430/8 | €3,240,924 | €736,191 | -€2.5m | -77.3% |
| Trade debts | 44 | €29,283,313 | €34,779,248 | +€5.5m | +18.8% |
| Suppliers | 440/4 | €29,283,313 | €34,779,248 | +€5.5m | +18.8% |
| Taxes, remuneration and social security | 45 | €318,248 | €783,172 | +€464,924 | +146% |
| Taxes | 450/3 | - | €415,058 | +€415,058 | |
| Remuneration and social security | 454/9 | €318,248 | €368,114 | +€49,866 | +15.7% |
| Other amounts payable | 47/48 | - | €4,868 | +€4,868 | |
| Accrued charges and deferred income | 492/3 | €915,691 | €582,628 | -€333,063 | -36.4% |
| Operating income | 70/76A | €22,505,083 | €25,164,504 | +€2.7m | +11.8% |
| Turnover | 70 | €21,551,917 | €24,782,987 | +€3.2m | +15.0% |
| Other operating income | 74 | €953,166 | €381,517 | -€571,649 | -60.0% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Operating charges | 60/66A | €23,315,006 | €25,383,235 | +€2.1m | +8.9% |
| Goods for resale, raw materials and consumables | 60 | €10,998,815 | €13,155,400 | +€2.2m | +19.6% |
| Purchases | 600/8 | €7,541,774 | €13,201,969 | +€5.7m | +75.1% |
| Change in stocks: decrease (increase) | 609 | €3,457,041 | -€46,569 | -€3.5m | |
| Services and other goods | 61 | €9,013,754 | €7,072,044 | -€1.9m | -21.5% |
| Remuneration, social security and pensions | 62 | €2,187,783 | €2,780,793 | +€593,010 | +27.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €261,773 | €232,697 | -€29,076 | -11.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €217,708 | €2,029,981 | +€1.8m | +832% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €0 | - | = | |
| Other operating charges | 640/8 | €480,181 | €107,742 | -€372,440 | -77.6% |
| Non-recurring operating charges | 66A | €154,992 | €4,580 | -€150,412 | -97.0% |
| Operating profit (loss) | 9901 | -€809,923 | -€218,731 | +€591,192 | +73.0% |
| Financial income | 75/76B | €5,426 | €210,822 | +€205,396 | +3,785% |
| Recurring financial income | 75 | €5,426 | €210,822 | +€205,396 | +3,785% |
| Income from current assets | 751 | - | €53 | +€53 | |
| Other financial income | 752/9 | €5,426 | €210,769 | +€205,343 | +3,784% |
| Financial charges | 65/66B | €448,230 | €1,253,463 | +€805,233 | +180% |
| Recurring financial charges | 65 | €448,230 | €1,253,463 | +€805,233 | +180% |
| Debt charges | 650 | €170,764 | €155,371 | -€15,393 | -9.0% |
| Other financial charges | 652/9 | €277,466 | €1,098,092 | +€820,626 | +296% |
| Profit (loss) for the period before taxes | 9903 | -€1,252,727 | -€1,261,372 | -€8,645 | -0.7% |
| Income taxes | 67/77 | €14,269 | €58,847 | +€44,579 | +312% |
| Taxes | 670/3 | €14,269 | €58,847 | +€44,579 | +312% |
| Profit (loss) for the period | 9904 | -€1,266,995 | -€1,320,219 | -€53,224 | -4.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,266,995 | -€1,320,219 | -€53,224 | -4.2% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.